CTLA4 anticorps (C-Term) (PE-Cy5)

N° du produit ABIN1713013

Cet anticorps Lapin Polyclonal détecte spécifiquement CTLA4 dans FACS et WB. Il présente une réactivité envers Humain, Souris, Rat, Boeuf (Vache) et Chien.

Aperçu rapide pour CTLA4 anticorps (C-Term) (PE-Cy5) (ABIN1713013)

Antigène: CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Reactivité: Humain, Souris, Rat, Boeuf (Vache), Chien

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CTLA4 est conjugé à/à la PE-Cy5

Application: Flow Cytometry (FACS), Western Blotting (WB)

Détail du produit anti-CTLA4 anticorps (PE-Cy5)

Épitope: C-Term

Réactivité croisée: Humain, Souris, Rat

Homologie: Dog,Cow,Sheep,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CTLA-4/CD152

Isotype: IgG

Information d'application

Indications d'application: FCM(1:100-500)
Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur CTLA4

Antigène: CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Autre désignation: CTLA4

Sujet:

Synonyms: CD, GSE, GRD4, CD152, CTLA-4, IDDM12, CELIAC3, Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, CTLA4

Background: Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28.

ID gène: 1493

UniProt: P16410

Pathways: Cancer Immune Checkpoints